Most lately, it's been discovered that conolidine and the above derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in identical locations as classical opioid receptors, it binds into a big selection of endogenous opioids. Not like most opioid receptors, this receptor acts as a scavenger and won't https://pault963siw8.wikigdia.com/user